Cargando…

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

BACKGROUND: Some tuberculosis (TB) treatment guidelines recommend daily TB treatment in both the intensive and continuation phases of treatment in HIV-positive persons to decrease the risk of relapse and acquired drug resistance. However, guidelines vary across countries, and treatment is given 7, 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crabtree-Ramirez, Brenda, Jenkins, Cathy A., Shepherd, Bryan E., Jayathilake, Karu, Veloso, Valdilea G., Carriquiry, Gabriela, Gotuzzo, Eduardo, Cortes, Claudia P., Padgett, Dennis, McGowan, Catherine, Sierra-Madero, Juan, Koenig, Serena, Pape, Jean W., Sterling, Timothy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985331/ https://www.ncbi.nlm.nih.gov/pubmed/35382770 http://dx.doi.org/10.1186/s12879-022-07330-5

Ejemplares similares

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
por: Carriquiry, Gabriela, et al.
Publicado: (2015)

Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort
por: Carriquiry, Gabriela, et al.
Publicado: (2018)

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America
por: Crabtree-Ramírez, Brenda, et al.
Publicado: (2016)

Use of Third Line Antiretroviral Therapy in Latin America
por: Cesar, Carina, et al.
Publicado: (2014)

Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors
por: Núñez, Isaac, et al.
Publicado: (2022)

Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis
por: Cortes, Claudia P., et al.
Publicado: (2013)

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters
por: Crabtree-Ramírez, Brenda, et al.
Publicado: (2011)

Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study
por: Crabtree‐Ramírez, Brenda E, et al.
Publicado: (2019)

Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America
por: Fink, Valeria I., et al.
Publicado: (2018)

CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
por: Luz, Paula M., et al.
Publicado: (2015)

Monitoring of HIV treatment in seven countries in the WHO Region of the Americas
por: Belaunzarán-Zamudio, Pablo F, et al.
Publicado: (2015)

Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil
por: Castilho, Jessica L, et al.
Publicado: (2019)

A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy
por: Wolff, Marcelo J., et al.
Publicado: (2017)

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America
por: Castilho, Jessica L, et al.
Publicado: (2021)

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America
por: Cesar, Carina, et al.
Publicado: (2016)

Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study
por: Caro-Vega, Yanink, et al.
Publicado: (2022)

Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?
por: Caro-Vega, Yanink, et al.
Publicado: (2013)

Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America
por: Belaunzaran-Zamudio, Pablo F., et al.
Publicado: (2020)

Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America
por: Cesar, Carina, et al.
Publicado: (2010)

Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy
por: Koethe, John R., et al.
Publicado: (2016)

Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017
por: Yohannes, Nathaniel T, et al.
Publicado: (2021)

Is substance use associated with HIV cascade outcomes in Latin America?
por: De Boni, Raquel B., et al.
Publicado: (2018)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Comparative HIV-1 Proviral Dynamics in Two Individuals That Maintained Viral Replication Control with or without Antiretroviral Therapy following Superinfection
por: de Azevedo, Suwellen Sardinha Dias, et al.
Publicado: (2022)

Virologic, Immunologic and Clinical Responses in Foreign-Born versus US-Born HIV-1 Infected Adults Initiating Antiretroviral Therapy: An Observational Cohort Study
por: Parrish, Deidra D., et al.
Publicado: (2012)

HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts
por: Castilho, Jessica L, et al.
Publicado: (2015)

The cost of antiretroviral therapy in Haiti
por: Koenig, Serena P, et al.
Publicado: (2008)

Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low‐ and middle‐income countries
por: Pettit, April C, et al.
Publicado: (2019)

The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead
por: Crabtree‐Ramírez, Brenda, et al.
Publicado: (2020)

Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean
por: Masys, DR, et al.
Publicado: (2009)

Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression
por: Rebeiro, Peter F, et al.
Publicado: (2016)

475. Describing the impact of the COVID-19 pandemic on HIV care in Latin America
por: Person, Anna K, et al.
Publicado: (2020)

Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America
por: Coelho, Lara E., et al.
Publicado: (2022)

Clinical Spectrum of Oral Secondary Syphilis in HIV-Infected Patients
por: Ramírez-Amador, Velia, et al.
Publicado: (2013)

381. HIV Patients with COVID-19 Hospitalized in a Tertiary Care Center in Mexico City
por: Espejo Ortiz, Cristian E, et al.
Publicado: (2020)

Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
por: Rodrigues, Amanda, et al.
Publicado: (2021)

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
por: Torres, Thiago Silva, et al.
Publicado: (2013)

Drug Use and Receipt of Highly Active Antiretroviral Therapy among HIV-Infected Persons in Two U.S. Clinic Cohorts
por: McGowan, Catherine C., et al.
Publicado: (2011)

Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ufgf49h2kf7gnuearjtr554a99